Costs Associated with Surgically Treated Cases of Abdominal Cystic Echinococcosis: A Single Center's Experience from 2008 to 2014, Pavia, Italy.

Cystic echinococcosis (CE) is a globally distributed zoonosis caused by the Echinococcus granulosus sensu lato species complex. Four approaches are available for treatment of abdominal CE: surgery, percutaneous aspiration, chemotherapy with albendazole, and watch-and-wait. Allocation of patients to these different treatment options mainly depends on the stage of the cystic lesion. However, as available guidelines are not widely followed, surgery is often applied even without the correct indication outside referral centers. This is not only a disadvantage for the patient, but also a waste of money. In this study, we evaluated the cost of the surgical approach for abdominal CE by analyzing hospitalization costs for 14 patients admitted to the General Surgery Ward at the "San Matteo" Hospital Foundation in Pavia, Italy, from 2008 through 2014. We found that the total cost of a single hospitalization, including hospital stay, surgical intervention, personnel, drugs, and administrative costs ranged from €5,874 to 23,077 (median €11,033) per patient. Our findings confirm that surgery can be an expensive option. Therefore, surgical intervention should be limited to cyst types that do not benefit from nonsurgical therapies and appropriate case management can best be accomplished by using a cyst stage-specific approach.

[1]  C. Fìlice,et al.  Long-term Sonographic and Serological Follow-up of Inactive Echinococcal Cysts of the Liver: Hints for a “Watch-and-Wait” Approach , 2014, PLoS neglected tropical diseases.

[2]  E. Brunetti,et al.  Cystic echinococcosis of the liver: A primer for hepatologists. , 2014, World journal of hepatology.

[3]  T. Piseddu,et al.  A retrospective study on burden of human echinococcosis based on Hospital Discharge Records from 2001 to 2009 in Sardinia, Italy. , 2012, Acta tropica.

[4]  E. Brunetti,et al.  Cystic Echinococcosis: Chronic, Complex, and Still Neglected , 2011, PLoS neglected tropical diseases.

[5]  E. Brunetti,et al.  Efficacy and safety of PAIR for cystic echinococcosis: experience on a large series of patients from Bulgaria. , 2011, The American journal of tropical medicine and hygiene.

[6]  A. D. da Silva Human Echinococcosis: A Neglected Disease , 2010, Gastroenterology research and practice.

[7]  E. Brunetti,et al.  Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. , 2010, Acta tropica.

[8]  C. Budke,et al.  Global Socioeconomic Impact of Cystic Echinococcosis , 2006, Emerging infectious diseases.

[9]  Laura L. Beaty Understanding Diagnostic Related Groups (DRGs) and Inpatient Hospital Reimbursement , 2005, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

[10]  H. Carabin,et al.  Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis. , 2005, Trends in parasitology.

[11]  D. McManus,et al.  Molecular epidemiology of cystic echinococcosis , 2003, Parasitology.

[12]  H. Carabin,et al.  Analysis of the economic impact of cystic echinococcosis in Spain. , 2010, Bulletin of the World Health Organization.

[13]  C. Fìlice,et al.  Echinococcosis in humans: clinical aspects, diagnosis and treatment. , 2001 .